Advanced Or Metastatic Hepatocellular Carcinoma clinical trials

Explore recruiting advanced or metastatic hepatocellular carcinoma clinical trials.

Recruiting advanced or metastatic hepatocellular carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Or Metastatic Hepatocellular Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Atezolizumab and Bevacizumab, with and without Tiragolumab, In Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma

Belgium, France, Italy, Germany, Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Randomized Study to Evaluate the Optimized Dose, Safety, and Efficacy of Livmoniplimab in Combination with Budigalimab for locally advanced or Metastatic Hepatocellular Carcinoma patients who have progressed after an approved immune checkpoint inhibitor containing regimen in First-Line HCC

France, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

C6461013 - An Interventional Open-label Phase 1b/2 Study to Evaluate Safety, Pharmacokinetics, and Preliminary Efficacy of PF-08634404 as Monotherapy and Combination Therapy in Adult Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma

Spain, Italy, Germany, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2/3, Randomized Study to Evaluate the Optimized dose, Safety, and Efficacy of Livmoniplimab in Combination with Budigalimab in Subjects with Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) who have not previously received systemic treatment

Italy, France, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Advanced Or Metastatic Hepatocellular Carcinoma trials by city

Advanced Or Metastatic Hepatocellular Carcinoma clinical trials

Recruiting advanced or metastatic hepatocellular carcinoma studies right now

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)

FOG-001 in Locally Advanced or Metastatic Solid Tumors

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Also recruiting in Europe

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Atezolizumab and Bevacizumab, with and without Tiragolumab, In Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma

C6461013 - An Interventional Open-label Phase 1b/2 Study to Evaluate Safety, Pharmacokinetics, and Preliminary Efficacy of PF-08634404 as Monotherapy and Combination Therapy in Adult Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma

A Phase 2/3, Randomized Study to Evaluate the Optimized dose, Safety, and Efficacy of Livmoniplimab in Combination with Budigalimab in Subjects with Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) who have not previously received systemic treatment

Advanced Or Metastatic Hepatocellular Carcinoma trials by city

Other conditions